|
⚲
|
| Keyboard |
| Gupta Rishi
✚
|
|
|---|---|
| CIK # | 0001537370 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001537370] | |
| 4 | [0001537370] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Enliven Therapeutics Inc | |
| Gupta Rishi | |
| Turnstone Biologics Corp | |
| Verona Pharma PLC | |
| Dimension Therapeutics Inc | |
| Project Sage Oldco Inc | |
| ChemoCentryx Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-02-12 | Grant | 33,989 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2026-02-12 | Grant | 1,580 | $0.00 | |
|
Turnstone Biologics Corp TSBX
Common Stock
|
2025-08-08 | Tender | 3,099,265 | ||
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2025-02-06 | Grant | 20,491 | $0.00 | |
|
Turnstone Biologics Corp TSBX
Stock Option (Right to Buy) · derivative
|
2024-06-03 | Grant | 12,770 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2024-05-16 | Sell | 33,300 | $22.14 | 737,262 |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2024-05-16 | Sell | 1,000,000 | $22.14 | 22,140,000 |
|
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
|
2024-02-13 | Grant | 16,835 | $0.00 | |
|
Turnstone Biologics Corp TSBX
Stock Option (Right to Buy) · derivative
|
2023-10-16 | Grant | 25,540 | $0.00 | |
|
Turnstone Biologics Corp TSBX
Series B-1 Preferred Stock · derivative
|
2023-07-20 | Conversion | 937,372 | ||
|
Turnstone Biologics Corp TSBX
Series C Preferred Stock · derivative
|
2023-07-20 | Conversion | 266,240 | ||
|
Turnstone Biologics Corp TSBX
Series D Preferred Stock · derivative
|
2023-07-20 | Conversion | 229,158 | ||
|
Turnstone Biologics Corp TSBX
Common Stock
|
2023-07-20 | Conversion | 2,682,599 | ||
|
Turnstone Biologics Corp TSBX
Common Stock
|
2023-07-20 | Buy | 416,666 | $12.00 | 4,999,992 |
|
Turnstone Biologics Corp TSBX
Series B-2 Preferred Stock · derivative
|
2023-07-20 | Conversion | 1,249,829 | ||
|
Enliven Therapeutics Inc ELVN
Stock Options (Right to Buy) · derivative
|
2023-05-17 | Option exercise | 2,125 | $0.00 | |
|
Enliven Therapeutics Inc ELVN
Common Stock
|
2023-05-17 | Option exercise | 2,125 | $4.28 | 9,095 |
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2023-05-15 | Sell | 345,313 | $20.00 | 6,906,260 |
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2023-05-15 | Sell | 14,400 | $21.96 | 316,224 |
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2023-05-12 | Sell | 43,200 | $21.64 | 934,848 |
| showing 20 of 39 most recent transactions | |||||